Should the Intra-Aortic Balloon Pump Be Used in Acute MI with Cardiogenic Shock?

Holger Thiele, MD, of the University of Leipzig Heart Center, Germany, gives an interview at the European Society of Cardiology Congress 2012 about the large-scale trial he and his colleagues conducted to assess the mortality benefit of the intra-aortic balloon pump (IABP) in patients with myocardial infarction complicated by cardiogenic shock. He discusses the results of the randomized IABP-SHOCK II study.